Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02762929 · ClinicalTrials.gov registry record · Phase 2
Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
A Phase 2 study, sponsored by Heron Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 430
- Enrollment target
NCT02762929: Completed Phase 2 study, sponsored by Heron Therapeutics.
NCT02762929 is a Phase 2 study that has completed, run by Heron Therapeutics. The registered enrollment target is 430 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (223% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02762929, a Phase 2 study, has completed, sponsored by Heron Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 430 participants
- Enrollment target
Study Summary
A Phase 2, Randomized, Controlled, Multicenter, Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
Primary Outcome
The SPI is derived by summing the pain intensity score weighted by the scheduled time duration. SPI0-24 will be calculated by summing the Pain intensity (PI) score at the relevant time points weighted by the scheduled time duration since the prior PI assessment as follows: SPI0-24= PI1+PI2+2\*PI4+2\*PI6+2\*PI8+2\*PI10+2\*PI12+2\*PI14+4\*PI18+6\*PI24. Min = 0 (if PI=0 at every time) and Max = 240 (if PI=10 at every time).
Interventions
- DRUG Bupivacaine HCl
- DRUG HTX-002
- DRUG HTX-011A
- BIOLOGICAL Saline Placebo
- DRUG HTX-011B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-03 |
| Phase | Phase 2 |
What the finished NCT02762929 record still lists
NCT02762929 is an interventional study that assigns participants to a tested intervention. The registered 430 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (223% higher).
The record links to 0 conditions, and to 5 interventions - of which Bupivacaine HCl is the first listed.
NCT02762929 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02762929 about?
NCT02762929 is a clinical study titled "Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy". A Phase 2, Randomized, Controlled, Multicenter, Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy
What is the current status of trial NCT02762929?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 430 participants. The study started on 2016-05. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02762929?
The interventions under investigation include: Bupivacaine HCl (DRUG), HTX-002 (DRUG), HTX-011A (DRUG), Saline Placebo (BIOLOGICAL), HTX-011B (DRUG).
Who is sponsoring clinical trial NCT02762929?
This trial is sponsored by Heron Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02762929's enrollment target sits among peer trials
430 90th of 2000 higher than 1,910 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05327023 · 430 participants · Phase 1
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- NCT05457985 · 430 participants · NA
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
- NCT05532982 · 430 participants
Parkinson's Disease in Asian Americans
- NCT05844891 · 430 participants · NA
Telehealth-Enhanced Asthma Care for Home After the Emergency Room
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia